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Abstract
A retrospective population based survey of patients born with holoprosencephaly in South-Eastern Hungary between July I, 1992 
and June 30, 2006 was performed. All live birth cases with craniofacial and non-craniofacial abnormalities were included in the 
study. A total of 9 patients (5 boys and 4 girls) were found with holoprosencephaly among 185 486 live births, which correspond 
to a birth prevalence of 0.49 per 10 000 live births (95% confidence interval [Cl]: 0.17-0.80). These figures were similar to those 
ones found in New York State and several European regions. In our series one newborn had trisomy 13. Eight patients did not 
have chromosomal abnormalities on routine testing, 4 of them had craniofacial abnormalities only and another 4 showed non- 
craniofacial anomalies as well. Three patients died in the neonatal period and another one in childhood. Patients surviving the 
neonatal period had intellectual and motor handicap, and epilepsy.
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Holoprosencephaly is a complex congenital brain malforma­
tion characterized by failure of the forebrain to separate into 
two hemispheres.1'3 Forebrain malformations range from mild 
(lobar) to complete (alobar) holoprosencephaly.’0 Facial 
abnormalities are frequently associated with holoprosence­
phaly. Mild forms of facial dysmorphic features are hypoplasia 
of the nasal bridge, hypotelorism, and single central incisor; 
more severe forms include median cleft lip, cebocephaly, eth- 
mocephaly, and cyclopia.1"3
Etiological heterogeneity has been revealed. Holoprosence­
phaly can be associated with chromosomal anomalies, occur as 
part of a syndrome, or be due to mutations in one of at least 12 
known holoprosencephaly-associated genes.4 *'6 Teratogenic 
factors, such as maternal diabetes and exposure to aspirin, alco­
hol, or smoking in the periconceptional period are also sup­
posed to cause this malformation.7,8 The etiology, however, 
remains unknown in a large number of patients.
Diverse data are available on the epidemiology of 
holoprosencephaly from various countries and regions.9' 14 Our 
aim was to perform a population based retrospective study in 
order to survey the live birth prevalence rate of this malforma­
tion and describe the associated abnormalities and clinical fea­
tures as correctly as possible in a region in Hungary between 
1992 and 2006.
Patients and Methods
All children in Hungary are assigned to a pediatrician and her/his 
clinic, therefore children bom with holoprosencephaly in the 
South-Eastern region (Dél-Alföld -  South Great Plain) in Hungary 
between July 1, 1992 and June 30, 2006 were ascertained by searching 
the databases of the pediatric clinics. All pediatricians in the region 
were approached by questionnaires and requested to report on patients 
with holoprosencephaly. They were encouraged also by telephone 
interviews and field trips to provide information on these patients in 
order to compile a register as complete as possible. As severe cases 
of holoprosencephaly with striking dysmorphic features were treated 
in the Neonatal Intensive Care Units, or Neonatal Wards in the hospi­
tals, the survey was extended to these departments in the region as 
well. Demographic data were collected from the Hungarian Central 
Statistical Office.
The diagnosis of holoprosencephaly was always confirmed by cra­
nial ultrasound, CT and/or MRI, performed by conventional protocols.
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Table 1. Group 1. Clinical features of patients with holoprosencephaly and craniofacial abnormalities
Patient Sex Age* Associated abnormalities
Developmental
delay
Intellectual
disability
Neurological
findings Epilepsy Comments
1 F NR Cebocephaly + + Spastic quadriparesis - Death at the age of 5 years 
No autopsy
2 M 5y Hypotelorism
Midfacial dysmorphic 
features
+ + Spastic quadriparesis +
3 M My Hypotelorism
Midfacial dysmorphic 
features
+ + Spastic quadriparesis +
4 M 13y Bilateral microphthalmos 
Bilateral optic nerve 
coloboma Cleft lip 
and palate
+ + Spastic quadriparesis +
Abbreviations: F, female, M, male, y, years, NR, not relevant. 
* age at last follow up
An attempt has been made to classify our cases into three groups 
according to presentation:
Group 1. Holoprosencephaly with craniofacial (eye, nose, ear, 
mouth and jaw) abnormalities only. These craniofacial abnorm­
alities have been regarded as part of the holoprosencephaly 
sequence.11
Group 2. Holoprosencephaly in association with noncranio- 
facial abnormalities in addition to craniofacial abnormalities.
Group 3. Holoprosencephaly in association with chromoso­
mal anomalies.
A detailed analysis of the patients with holoprosencephaly was carried 
out. Clinical records were retrospectively reviewed for family history, 
parental consanguinity and age, maternal and birth history, possible 
environmental factors, neonatal course, developmental milestones, 
and epileptic seizures. Detailed clinical and neurological examinations 
were carried out. Electroencephalography was performed according to 
the 10-20 system. Chromosomal analysis by routine G-banding tech­
nique was carried out in all patients. Molecular cytogenetic studies or 
mutation analysis of genes responsible for holoprosencephaly were 
not performed.
We calculated the birth prevalence of holoprosencephaly per 
10 000 live births in the region between July 1, 1992 and June 30, 
2006. The numerator was the total number of cases with holoprosen­
cephaly in live births, and the denominator was the total number of 
live births during the same period of time.
Statistical analysis was performed by using the SPSS 15.0 program 
(SPSS Inc., an IBM Company, Chicago, Illinois, USA). We calculated 
95% confidence intervals (95% Cl) on the basis of approximation to 
the binomial distribution.
Results
There were 185.486 live births in the area between July 1, 1992 
and June 30, 2006. The total number of patients bom with 
holoprosencephaly was 9 (5 boys, 4 girls) in this period of time, 
which means that the prevalence at birth was 0.49 per 10 000
live births (95% Cl: 0.17-0.80). Four patients (Group 1, 
Patients 1-4, Table 1) had only brain and craniofacial 
malformations, 4 children (Group 2, Patients 1-4, Table 2) had 
also non-craniofacial anomalies in addition to holoprosence­
phaly and craniofacial abnormalities and one newborn had 
trisomy 13 (Group 3, Patient 1, Table 3).
Cranial ultrasound was performed for all patients. Three 
patients (Group 2, Patients 1 and 2, and the infant in Group 
3) had alobar holoprosencephaly. CT images in addition to 
ultrasound were available for two patients (Group 1, Patient 
3 and Group 2, Patient 3) with semilobar holoprosencephaly, 
while MRI was carried out for 4 children (Group 1, Patients 
1, 2, and 4, and Group 2, Patient 4). Patient 1 in Group 1 had 
alobar holoprosencephaly with a large monoventricle, fused 
thalami and absence of the third ventricle. The quadrigeminal 
plate and aqueduct were not recognizable. Patients 2 and 4 in 
Group 1 and Patient 4 in Group 2 had abnormal gyral config­
uration, absence of the anterior portion of the interhemispheric 
fissure, corpus callosum agenesis and a crescent-shaped mono­
ventricle, continuous with a small third ventricle. The thalami 
were partially separated and the individual basal ganglia were 
not recognizable. The aqueduct appeared patent below the 
quadrigeminal plate.
The routine chromosomal analysis did not show abnormal­
ities in 8 patients. There was no parental consanguinity or 
familial occurrence of the malformation. Three patients were 
the product of preterm delivery, while the other neonates were 
bom at term, none o f them diagnosed prenatally. There were no 
twins among the patients. Two patients with multiple defects 
(Group 2, Patients 1, 2, Table 2) and the infant with trisomy 
13 (Group 3, Patient 1, Table 3) died in the neonatal period, 
while one patient (Group 1, Patient 1, Table 1) with holopro­
sencephaly and craniofacial abnormalities died in childhood. 
The ages of patients surviving the neonatal period ranged from 
5 to 13 years at the time of the survey. Maternal diabetes was 
diagnosed in one patient (Group 2, Patient 4, Table 2), prenatal 
risk factors were not identified in the other cases. All patients
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sequence."
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nique was carried out in all patients. Molecular cytogenetic studies or 
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2006. The numerator was the total number of cases with holoprosen­
cephaly in live births, and the denominator was the total number of 
live births during the same period of time.
Statistical analysis was performed by using the SPSS 15.0 program 
(SPSS Inc., an IBM Company, Chicago, Illinois, USA). We calculated 
95% confidence intervals (95% Cl) on the basis of approximation to 
the binomial distribution.
Results
There were 185.486 live births in the area between July 1, 1992 
and June 30, 2006. The total number of patients bom with 
holoprosencephaly was 9 (5 boys, 4 girls) in this period of time, 
which means that the prevalence at birth was 0.49 per 10 000
live births (95% Cl: 0.17-0.80). Four patients (Group 1, 
Patients 1-4, Table 1) had only brain and craniofacial 
malformations, 4 children (Group 2, Patients 1-4, Table 2) had 
also non-craniofacial anomalies in addition to holoprosence­
phaly and craniofacial abnormalities and one newborn had 
trisomy 13 (Group 3, Patient 1, Table 3).
Cranial ultrasound was performed for all patients. Three 
patients (Group 2, Patients 1 and 2, and the infant in Group 
3) had alobar holoprosencephaly. CT images in addition to 
ultrasound were available for two patients (Group 1, Patient 
3 and Group 2, Patient 3) with semilobar holoprosencephaly, 
while MRI was carried out for 4 children (Group 1, Patients 
1, 2, and 4, and Group 2, Patient 4). Patient 1 in Group 1 had 
alobar holoprosencephaly with a large monoventricle, fused 
thalami and absence of the third ventricle. The quadrigeminal 
plate and aqueduct were not recognizable. Patients 2 and 4 in 
Group 1 and Patient 4 in Group 2 had abnormal gyral config­
uration, absence of the anterior portion of the interhemispheric 
fissure, corpus callosum agenesis and a crescent-shaped mono­
ventricle, continuous with a small third ventricle. The thalami 
were partially separated and the individual basal ganglia were 
not recognizable. The aqueduct appeared patent below the 
quadrigeminal plate.
The routine chromosomal analysis did not show abnormal­
ities in 8 patients. There was no parental consanguinity or 
familial occurrence of the malformation. Three patients were 
the product of preterm delivery, while the other neonates were 
born at term, none of them diagnosed prenatally. There were no 
twins among the patients. Two patients with multiple defects 
(Group 2, Patients 1, 2, Table 2) and the infant with trisomy 
13 (Group 3, Patient 1, Table 3) died in the neonatal period, 
while one patient (Group 1, Patient 1, Table 1) with holopro­
sencephaly and craniofacial abnormalities died in childhood. 
The ages of patients surviving the neonatal period ranged from 
5 to 13 years at the time of the survey. Maternal diabetes was 
diagnosed in one patient (Group 2, Patient 4, Table 2), prenatal 
risk factors were not identified in the other cases. All patients
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Table 2. Group 2. Clinical features of patients with holoprosencephaly, craniofacial and non-craniofacial abnormalities
Patient Sex Age*
Associated
abnormalities
Developmental
delay
Intellectual
disability Neurological findings Epilepsy Comments
1 F NR Bilateral
microphthalmos 
Polydactyly 
Thyroid hypoplasia 
Atrial septal 
defect
Imperforate anus 
Rectovaginal fistula
NR NR NR NR Neonatal death 
Autopsy, no 
histology
2 M NR Cyclopia
Proboscis
Cryptorchism
NR NR NR NR Neonatal death 
Autopsy, no 
histology
3 M 7y Left microphthalmos 
Micropenis
+ + Generalized hypotonia 
Paucity of spontaneous 
movements
+
4 F 8y Cleft lip and palate 
Pyloric stenosis
+ + Spastic quadriparesis + Maternal
diabetes
Abbreviations: F, female, M, male, y, years, NR, not relevant.
* age at last follow up
Table 3. Group 3. Clinical features of a patient with holoprosencephaly in association with chromosomal anomaly
Patient Sex Age Associated abnormalities
I F NR Cleft lip and palate
Postaxial polydactyly 
(hands, bilateral), 
polysyndactytly 
(right foot)
Hypoplastic left heart
Abbreviations: F, female, NR, not relevant
Developmental Intellectual Neurological
delay disability findings Epilepsy Comments
NR NR NR NR Neonatal death
47, X X , trisomy 13 
(Patau syndrome) 
Autopsy, no histology
had microcephaly. Craniofacial anomalies of various severities 
with dysmorphic features, listed in Tables 1-3 were found in all 
patients. Non-craniofacial defects in Group 2 (Patients 1-4, 
Table 2) included limb, endocrine, genital, heart and gastroin­
testinal anomalies. The patient with trisomy 13 (Group 3, Table 
3) had limb and heart defects in addition to craniofacial anoma­
lies. The development of all patients who survived the neonatal 
period was delayed and all of them had severe intellectual dis­
ability. Spastic quadriparesis was observed in 5 children and 
generalized hypotonia in one child. Epileptic seizures appeared 
in 5 patients (Groups 1, 2, Tables 1, 2).
Discussion
Differences in the birth prevalence rate of holoprosencephaly can 
be explained by the survey methods employed. In a recent review 
Orioli and Castilla13 compared birth prevalence rates published in 
several studies from various parts of the world. They suggested 
that the birth prevalence rate was lower than 1 per 10 000 if live 
births and still births were only included in the survey, while the 
rate was above 1 per 10 000 if terminated pregnancies were also 
included.
Live birth prevalence rate was surveyed in this study and the 
figure of 0.49 per 10 000 between 1992 and 2006 was similar to 
figures found in New York State", a region in the UK (North 
West Thames)14, and three Italian regions (Emilia Romagna, 
North East Italy and Sicily). 14
The range of craniofacial abnormalities in the patients in 
this study extended from very severe defects with cyclopia to 
milder forms of midfacial dysmorphic features as described 
in the literature.1,2 The mesencephalic neural crest forms the 
membranous bones of the face in addition to ectodermal struc­
tures and impaired formation or migration of the mesencepha­
lic neural crest due to defective genetic expression in the 
longitudinal axis of the neural tube may result in midfacial 
hypoplasia.15 Indeed, a correlation between the degree of facial 
anomalies and the extent of the anatomic involvement o f the 
midbrain has been described.15 Non-craniofacial abnormalities 
can occur in more than half of the cases without chromosomal 
abnormalities.9,11 The ratio was similar in our study, 4 patients 
out of the 8 cases without chromosomal abnormalities had non- 
craniofacial defects as well.
One-third of the patients with holoprosencephaly in this sur­
vey were bom preterm. This finding is in agreement with
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earlier studies that showed that infants with holoprosencephaly 
were more likely than controls to be born preterm/very preterm 
or with low/very low birth weight.8 Predominance of either sex 
was not found in our study. Previous studies found that females 
had a greater risk than males for holoprosencephaly,8' 10'11 how­
ever the female predominance might have been due to a higher 
spontaneous abortion rate of males with holoprosencephaly.9,13
Maternal diabetes appears to be risk factor for holoprosence­
phaly.8’9 Rasmussen and co-workers found maternal diabetes in 
5 cases out of 63.9 The only case associated with maternal dia­
betes in our series represents a similar ratio despite the small 
number of cases. Other risk factors, such as periconceptional 
maternal exposure to aspirin, alcohol, or tobacco were not iden­
tified in our case series.
Trisomy 13 is frequently associated with holoprosence­
phaly.4 Rasmussen and co-workers found 8 cases out of 53 
patients,9 Olsen described 8 out of 78 cases,11 while one case 
out of 9 in this series had trisomy 13. However, holoprosence­
phaly with normal karyotype on routine chromosomal studies 
can also have genetic etiology.5,6 Mutation analyses of the 
holoprosencephaly genes or molecular cytogenetic techniques, 
however, were not available for our patients.
Some inaccuracy probably can not be avoided in such an 
epidemiological study, hence this survey also bears some lim­
itations. Live births with holoprosencephaly were only 
included in this study, because data on stillbirths or termi­
nated pregnancies were not available. Our prevalence rate 
might be an underestimate of the actual prevalence, since 
mildly affected children with holoprosencephaly might have 
been missed from surveillance. No etiology was found in a 
number of cases with multiple anomalies. The launch of a 
prospective study on a larger population will be considered 
in the near future.
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